Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
50
SDMHF Quote, Financials, Valuation and Earnings
Last price:
$193.00
Seasonality move
:
0.12%
Day range:
$193.00 - $193.00
52-week range:
$170.00 - $264.30
Dividend yield:
0.42%
P/E ratio:
63.04x
P/S ratio:
5.60x
P/B ratio:
3.91x
Volume:
--
Avg. volume:
2.6K
1-year change:
-5.41%
Market cap:
$18.8B
Revenue:
$3.3B
EPS (TTM):
$3.06
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Sartorius Stedim Biotech SA has -- downside to fair value with a price target of -- per share.
SDMHF vs. S&P 500
-
Over the past 5 trading days, Sartorius Stedim Biotech SA has underperformed the S&P 500 by -3.63% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Sartorius Stedim Biotech SA does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Sartorius Stedim Biotech SA has grown year-over-year revenues for 5 quarters straight. In the most recent quarter Sartorius Stedim Biotech SA reported revenues of $898.8M.
Earnings Growth
-
Sartorius Stedim Biotech SA has grown year-over-year earnings for 5 quarters straight. In the most recent quarter Sartorius Stedim Biotech SA reported earnings per share of $0.57.
Enterprise value:
21.4B
EV / Invested capital:
--
Price / LTM sales:
5.60x
EV / EBIT:
34.43x
EV / Revenue:
6.38x
PEG ratio (5yr expected):
1.10x
EV / Free cash flow:
126.22x
Price / Operating cash flow:
110.91x
Enterprise value / EBITDA:
21.80x
Gross Profit (TTM):
$1.5B
Return On Assets:
3.24%
Net Income Margin (TTM):
8.9%
Return On Equity:
6.52%
Return On Invested Capital:
3.87%
Operating Margin:
14.89%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Income Statement | ||||||
| Revenue | $3B | $3B | $3.4B | $801.4M | $898.8M | |
| Gross Profit | $1.4B | $1.3B | $1.5B | $337.4M | $368.9M | |
| Operating Income | $572.8M | $447M | $620.8M | $112.2M | $133.9M | |
| EBITDA | $828.7M | $773.3M | $980.5M | $198.2M | $231.5M | |
| Diluted EPS | $3.64 | $1.94 | $3.06 | $0.50 | $0.57 | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.7B | $1.8B | $1.6B | $1.8B | $1.7B | |
| Total Assets | $4.5B | $5.4B | $8.6B | $8.6B | $9.4B | |
| Current Liabilities | $1.2B | $1.1B | $1B | $972.1M | $1.7B | |
| Total Liabilities | $2.5B | $2.7B | $5.6B | $4.4B | $4.6B | |
| Total Equity | $2B | $2.7B | $3B | $4.2B | $4.8B | |
| Total Debt | $682.3M | $1.2B | $4B | $2.9B | $2.4B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $674.6M | $676M | $627.1M | $282.9M | $281M | |
| Cash From Investing | -$3B | -$359.5M | -$463M | -$77.3M | -$137M | |
| Cash From Financing | $2.4B | $278.5M | -$453.1M | -$11.1M | $7.4M | |
| Free Cash Flow | $167.1M | $316.7M | $169.3M | $205.8M | $146M | |
SDMHF
Sector
Market Cap
$18.8B
$23.9M
Price % of 52-Week High
73.02%
47.44%
Dividend Yield
0.42%
0%
Shareholder Yield
0.39%
-1.88%
1-Year Price Total Return
-5.41%
-18.29%
Beta (5-Year)
1.164
0.513
Dividend yield:
0.42%
Annualized payout:
$0.74
Payout ratio:
141.94%
Growth streak:
1 years
Technicals
8-day SMA
Buy
Level
$192.99
200-day SMA
Sell
Level
$221.81
Bollinger Bands (100)
Sell
Level
202.01 - 245.75
Chaikin Money Flow
Buy
Level
1.4K
20-day SMA
Buy
Level
$190.77
Relative Strength Index (RSI14)
Sell
Level
44.05
ADX Line
Sell
Level
10.5
Williams %R
Neutral
Level
-21.3905
50-day SMA
Sell
Level
$207.76
MACD (12, 26)
Buy
Level
50.79
25-day Aroon Oscillator
Sell
Level
-44
On Balance Volume
Sell
Level
-4.9K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.1916)
Buy
CA Score
(Annual)
Level (-0.029)
Buy
Beneish M-Score
(Annual)
Level (-2.7565)
Buy
Momentum Score
Level (8)
Buy
Ohlson Score
Level (-0.857)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Sartorius Stedim Biotech SA provides equipment and services for the development, quality assurance, and production processes of the biopharmaceutical industry. The firm offers a broad portfolio of products that focuses on all steps in the manufacture of a biopharmaceutical, as well as in process development as prerequisite procedures. Its technologies cover inter alia, cell line technologies, cell culture media, bioreactors, and a wide range of products for separation, purification, and concentration of biological intermediates and finished products, as well as solutions for storage and transportation. It also offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production. The company was founded on September 28, 1978 and is headquartered in Aubagne, France.
Stock Forecast FAQ
In the current month, SDMHF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The SDMHF average analyst price target in the past 3 months is --.
-
Where Will Sartorius Stedim Biotech SA Stock Be In 1 Year?
According to analysts, the consensus estimate is that Sartorius Stedim Biotech SA share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Sartorius Stedim Biotech SA?
Analysts are divided on their view about Sartorius Stedim Biotech SA share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Sartorius Stedim Biotech SA is a Sell and believe this share price will rise from its current level to --.
-
What Is Sartorius Stedim Biotech SA's Price Target?
The price target for Sartorius Stedim Biotech SA over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is SDMHF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Sartorius Stedim Biotech SA is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of SDMHF?
You can purchase shares of Sartorius Stedim Biotech SA via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Sartorius Stedim Biotech SA shares.
-
What Is The Sartorius Stedim Biotech SA Share Price Today?
Sartorius Stedim Biotech SA was last trading at $193.00 per share. This represents the most recent stock quote for Sartorius Stedim Biotech SA. Yesterday, Sartorius Stedim Biotech SA closed at $193.00 per share.
-
How To Buy Sartorius Stedim Biotech SA Stock Online?
In order to purchase Sartorius Stedim Biotech SA stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get SDMHF Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
SDMHF
Sector
P/E ratio
63.04x
21.37x
PEG ratio
1.10x
-0.01x
P/B ratio
3.91x
1.72x
Price / LTM sales
5.60x
1.45x
Growth Metrics
SDMHF
Sector
Revenue growth
12.15%
3.44%
Earnings growth
13.18%
15.03%
Revenue (5-year growth)
8.99%
6.25%
Earnings forecast
--
-$0.22
Profitability
SDMHF
Sector
Profitability FY 2025
$1.5B
$2.4M
Return on invested capital
3.87%
-33.32%
Return on assets
3.24%
-29.45%
Return on equity
6.52%
-40.29%
Earnings Date
Last Earnings Date
Feb
16
Next Earnings Date
Apr
23
Estimated Next Earnings Date
May
18
Balance Sheet
SDMHF
Sector
Total cash
$500.4M
$25.7M
Short term investments
$10.3M
$22.7M
Total assets
$9.4B
$70.6M
Long term debt
$2.4B
$2.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
46
Is NVDA Stock a Buy?
Market Cap: $4.3T
P/E Ratio: 36x
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 34x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 27x
Alerts
Buy
51
AAOI alert for Apr 3
Applied Optoelectronics, Inc. [AAOI] is up 20.3% over the past day.
Buy
59
SBAC alert for Apr 3
SBA Communications Corp. [SBAC] is up 18.96% over the past day.
Buy
55
VSAT alert for Apr 3
ViaSat, Inc. [VSAT] is up 18.73% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
